Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Kumar Halder

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
European Journal of Medicinal Chemistry|April 19, 2008
QSAR modelling of pancreatic beta-cell KATP channel openers R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(substituted phenylaminocarbonylamino)-2H-1-benzopyrans using MLR-FA techniquesSk Mahasin Alam, Soma Samanta, Amit Kumar Halder, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 1, 2015
Structural findings of phenylindoles as cytotoxic antimitotic agents in human breast cancer cell lines through multiple validated QSAR studiesNilanjan Adhikari, Amit Kumar Halder, Achintya Saha, et al.
Journal of Chemical Information and Modeling|May 16, 2019
QSAR-Co: An Open Source Software for Developing Robust Multitasking or Multitarget Classification-Based QSAR ModelsPravin Ambure, Amit Kumar Halder, Humbert González Díaz, et al.
Journal of Molecular Modeling|March 17, 2025
Structural insights into molecular and cellular level FXR binding potentials of GW4064 and LY2562175 hybrids by multi in silico modelling analysesTanmoy Banerjee, Soumya Mitra, Shuvam Sar, et al.
Future Medicinal Chemistry|November 25, 2021
Synthesis, anticancer activity, SAR and binding mode of interaction studies of substituted pentanoic acids: part IISanchita Datta, Amit Kumar Halder, Nilanjan Adhikari, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Shaping the Future of Obesity Treatment: In Silico Multi-Modeling of IP6K1 Inhibitors for Obesity and Metabolic DysfunctionIsmail Mondal, Amit Kumar Halder, Nirupam Pattanayak, et al.
Frontiers in Chemistry|August 29, 2022
Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancerSiddhartha Das Pramanik, Amit Kumar Halder, Ushmita Mukherjee, et al.
Computers in Biology and Medicine|March 24, 2023
Multi-model in silico characterization of 3-benzamidobenzoic acid derivatives as partial agonists of Farnesoid X receptor in the management of NAFLDSoumya Mitra, Amit Kumar Halder, Nilanjan Ghosh, et al.
European Journal of Medicinal Chemistry|December 24, 2014
Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agentsChanchal Mondal, Amit Kumar Halder, Nilanjan Adhikari, et al.
Future Medicinal Chemistry|August 3, 2019
Synthesis, anticancer activity, structure-activity relationship and binding mode of interaction studies of substituted pentanoic acidsSanchita Dutta, Amit Kumar Halder, Nilanjan Adhikari, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Medicinal Chemistry|April 19, 2008
QSAR modelling of pancreatic beta-cell KATP channel openers R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(substituted phenylaminocarbonylamino)-2H-1-benzopyrans using MLR-FA techniquesSk Mahasin Alam, Soma Samanta, Amit Kumar Halder, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 1, 2015
Structural findings of phenylindoles as cytotoxic antimitotic agents in human breast cancer cell lines through multiple validated QSAR studiesNilanjan Adhikari, Amit Kumar Halder, Achintya Saha, et al.
Journal of Chemical Information and Modeling|May 16, 2019
QSAR-Co: An Open Source Software for Developing Robust Multitasking or Multitarget Classification-Based QSAR ModelsPravin Ambure, Amit Kumar Halder, Humbert González Díaz, et al.
Journal of Molecular Modeling|March 17, 2025
Structural insights into molecular and cellular level FXR binding potentials of GW4064 and LY2562175 hybrids by multi in silico modelling analysesTanmoy Banerjee, Soumya Mitra, Shuvam Sar, et al.
Future Medicinal Chemistry|November 25, 2021
Synthesis, anticancer activity, SAR and binding mode of interaction studies of substituted pentanoic acids: part IISanchita Datta, Amit Kumar Halder, Nilanjan Adhikari, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Shaping the Future of Obesity Treatment: In Silico Multi-Modeling of IP6K1 Inhibitors for Obesity and Metabolic DysfunctionIsmail Mondal, Amit Kumar Halder, Nirupam Pattanayak, et al.
Frontiers in Chemistry|August 29, 2022
Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancerSiddhartha Das Pramanik, Amit Kumar Halder, Ushmita Mukherjee, et al.
Computers in Biology and Medicine|March 24, 2023
Multi-model in silico characterization of 3-benzamidobenzoic acid derivatives as partial agonists of Farnesoid X receptor in the management of NAFLDSoumya Mitra, Amit Kumar Halder, Nilanjan Ghosh, et al.
European Journal of Medicinal Chemistry|December 24, 2014
Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agentsChanchal Mondal, Amit Kumar Halder, Nilanjan Adhikari, et al.
Future Medicinal Chemistry|August 3, 2019
Synthesis, anticancer activity, structure-activity relationship and binding mode of interaction studies of substituted pentanoic acidsSanchita Dutta, Amit Kumar Halder, Nilanjan Adhikari, et al.
Pageof 4